Trial | NCT00015171  Report issue

Title

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    0
The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.
The objective of this study is to determine the safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment.
Study Started
Apr 30
1996
Primary Completion
May 31
1997
Study Completion
Jun 30
1997
Last Update
Jan 16
2017
Estimate

Drug Buprenorphine/naloxone

Criteria 

Inclusion Criteria:

DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female 18-59 yrs of age

Exclusion Criteria:

Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence
No Results Posted